v3.26.1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Operating Leases
In February 2026, the Company entered into a lease for 50,485 square feet of office space in San Jose, California, with a lease term of 102 months with one five-year option to extend the term of the lease. The monthly base rent is $128,737 and is subject to annual increases. The Company is not required to pay monthly base rent for the first six months. Under the terms of the lease, the Company expects to receive up to $3.8 million from the landlord as reimbursement for qualifying costs incurred in connection with the Company’s construction of tenant improvements. In the first quarter of 2026, the Company recorded a right-of-use asset of $6.6 million and a lease liability of $6.5 million related to the lease. As of June 30, 2026, lease payments have not yet commenced for the lease.
The Company also has a non-cancelable operating lease for an office building space, located in Santa Clara, California, with an original lease period expiring in May 2025 ("El Camino Lease"). On July 18, 2024, the Company extended the term of the El Camino Lease for an additional period of fourteen months commencing on June 1, 2025 and expiring July 31, 2026. On June 5, 2026, the Company extended the term of the El Camino Lease for an additional period of one month commencing on August 1, 2026 and expiring August 31, 2026 with an option to extend an additional one month to September 30, 2026.
The Company also has non-cancelable leases for a building used for research and development and warehouse space in Santa Clara, California with original lease period expiring in October 2026 ("Owen Lease"). On July 9, 2026, the Company extended the Owen Lease term for a period of two months commencing on November 1, 2026, and expiring December 31, 2026.
The Company also has a lease for office building space in Gallarate, Italy which expires in August 2027.
The Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2026 to 2029.
Supplemental information related to lease expense and valuation of the lease assets and lease liabilities are as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2026202520262025
Operating lease expense$600$312$1,014$623
Variable lease expense148136339346
Total lease expense$748$448$1,353$969
Cash paid for amounts included in the measurement of operating lease liabilities
$330$326$791$711
Leased assets obtained in exchange for new operating lease liabilities
$54$39$6,633$39
June 30, 2026December 31, 2025
Weighted average remaining lease term (in years)8.151.20
Weighted average discount rate6.28%6.95%
Future minimum lease payments under non-cancelable operating leases as of June 30, 2026 were as follows:
Year Ending December 31,
(in thousands)
Remainder of 2026$372 
20271,178 
20281,692 
20291,660 
20301,701 
Thereafter7,816 
Total operating lease payments14,419 
Less: imputed interest and tenant improvement allowance
(7,252)
Total operating lease liabilities$7,167 
As of June 30, 2026, the Company had no operating lease liabilities that had not commenced.
Purchase Commitments and Obligations
The Company has certain purchase commitments related to its inventory management with certain manufacturing suppliers based on the agreements or blanket purchase orders. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $4.2 million and $4.3 million as of June 30, 2026 and December 31, 2025, respectively.
Indemnification
The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company’s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.
The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.
Legal Contingencies
In October 2024, the Company received a civil investigative demand (“CID”) from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the “Investigation”). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals. The Company is cooperating with the Investigation but is currently unable to express a view regarding the likely duration, or ultimate outcome, of the Investigation. As of June 30, 2026, the Company has not recorded an accrual related to the Investigation. Depending on how the Investigation progresses, there may be a material impact on the Company’s business, results of operations, or financial condition.
From time to time, the Company may become involved in legal proceedings arising in the ordinary course of its business. Except with regards to the Investigation, the Company is not presently a party to any material legal proceedings that, if determined adversely to the Company, would have a material adverse effect on the Company.